SoCal Flipbooks

HM_StJoBurbank_Summer21_final

Issue link: https://blog.providence.org/i/1384268

Contents of this Issue

Navigation

Page 11 of 11

Providence Saint Joseph Medical Center Summer 2021 Providence Health System Southern California 3345 Michelson Drive, Suite 100 Irvine, CA 92612 Providence.org/SaintJoseph facebook.com/ProvidenceSaintJoseph The medical information contained in this newsletter should not be substituted for advice from your personal physician. NON-PROFIT ORG. U.S. POSTAGE P A I D TORRANCE, CA. PERMIT # 89 If you do not wish to receive future issues of this publication, please call 855-747-2247 and leave your name and complete address as it appears on the mailing panel. HEAD & NECK Principal Investigator: Dr. Ora Gordon Wake Forest's "WF97115" (ACUPUNCTURE) Summary: A phase 3 acupuncture study for radiation-induced xerostomia in patients with head and neck cancer LUNG Principal Investigator: Dr. Raul Mena Merck's "MK-7339-006" (KEYLYNK- 006) Summary: A phase 3 first-line study for metastatic non-squamous non-small-cell lung cancer Principal Investigator: Dr. Raul Mena Merck's "MK-7339-008" (KEYLYNK- 008) Summary: A phase 3 first-line study for metastatic squamous non-small-cell lung cancer NON-THERAPEUTIC STUDIES Principal Investigator: Dr. Ora Gordon MTG015: "MT-1410" Summary: A sample collection study for all cancers Principal Investigator: Dr. Ora Gordon JWCI "JWCI-Repository" Summary: A sample collection study for all cancers Principal Investigator: Dr. Erwin Grussie Myriad's "ONC-010" (EXET) Summary: A prospective registry study for breast cancer patients between 4 and 6.5 years post- diagnosis to evaluate the impact of the EndoPredict® test on extended endocrine treatment decisions and patient outcomes GASTROINTESTINAL Principal Investigator: Dr. Raul Mena Merck's "MK-7339-003" (LYNK-003) Summary: A phase 3 study for unresectable or metastatic colorectal cancer patients who have not progressed on FOLFOX w/ Bevacizumab GYNECOLOGY Principal Investigator: Dr. Erwin Grussie Astra Zeneca's "D601HC00002" (ADAGIO) Summary: A phase 2B study for recurrent or persistent uterine serous carcinoma Principal Investigator: Dr. Richard Friedman AIVITA Biomedical's "CL-OVA-P01-00-US" (AVOVA-1) Summary: A phase 2B study for patients with stage 3 or 4 epithelial ovarian, fallopian tube or primary peritoneal carcinoma after primary treatment Principal Investigator: Dr. Raul Mena Merck's "MK7339-001" (KEYLYNK-001) Summary: A phase 3 first-line study for BRCA non-mutated advanced epithelial ovarian cancer Disney Family Cancer Center Is Currently Enrolling Clinical Trials For more information, please contact our Clinical Research Team by email at DFCC_Clinical_Research@Providence.Org

Articles in this issue

Links on this page

view archives of SoCal Flipbooks - HM_StJoBurbank_Summer21_final